1. Home
  2. IVDA vs GNPX Comparison

IVDA vs GNPX Comparison

Compare IVDA & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVDA
  • GNPX
  • Stock Information
  • Founded
  • IVDA 2003
  • GNPX 2009
  • Country
  • IVDA United States
  • GNPX United States
  • Employees
  • IVDA N/A
  • GNPX N/A
  • Industry
  • IVDA Computer Software: Prepackaged Software
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IVDA Technology
  • GNPX Health Care
  • Exchange
  • IVDA Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • IVDA 6.7M
  • GNPX 6.6M
  • IPO Year
  • IVDA N/A
  • GNPX 2018
  • Fundamental
  • Price
  • IVDA $1.96
  • GNPX $0.23
  • Analyst Decision
  • IVDA
  • GNPX
  • Analyst Count
  • IVDA 0
  • GNPX 0
  • Target Price
  • IVDA N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • IVDA 161.4K
  • GNPX 3.6M
  • Earning Date
  • IVDA 08-13-2025
  • GNPX 08-08-2025
  • Dividend Yield
  • IVDA N/A
  • GNPX N/A
  • EPS Growth
  • IVDA N/A
  • GNPX N/A
  • EPS
  • IVDA N/A
  • GNPX N/A
  • Revenue
  • IVDA $7,148,449.00
  • GNPX N/A
  • Revenue This Year
  • IVDA $340.48
  • GNPX N/A
  • Revenue Next Year
  • IVDA N/A
  • GNPX N/A
  • P/E Ratio
  • IVDA N/A
  • GNPX N/A
  • Revenue Growth
  • IVDA 54.15
  • GNPX N/A
  • 52 Week Low
  • IVDA $1.27
  • GNPX $0.20
  • 52 Week High
  • IVDA $8.05
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • IVDA 41.16
  • GNPX 40.22
  • Support Level
  • IVDA $1.71
  • GNPX $0.22
  • Resistance Level
  • IVDA $2.09
  • GNPX $0.32
  • Average True Range (ATR)
  • IVDA 0.17
  • GNPX 0.03
  • MACD
  • IVDA -0.02
  • GNPX -0.01
  • Stochastic Oscillator
  • IVDA 12.05
  • GNPX 22.07

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: